Dare Bioscience, Inc.
DARE· Nasdaq
DAREDare Bioscience, Inc.
Filed Nov 16, 2015 · 10-Q · 47 days after period end · 0001564590-15-010798
| Metric | Q3 2015 | Q3 2014 | Q3 2013 |
|---|---|---|---|
| Revenue | — | $0.00 | — |
| Net Income | -$10.55M | -$5.56M | -$3.20M |
| EPS Diluted | -$0.39 | -$0.28 | -$4.40 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Dare Bioscience, Inc. · CIK 1401914 · Engraved from SEC EDGAR
ended Sep 30, 2015 · filed Nov 16, 2015 · 47 d after period end
